                         ˿µϣ20070408գ

07.04.07ûи
07.04.08, ӢȻйƻʵҽִ
07.04.08, Home˿԰棩Ŀͨ
07.04.08, һʮλѧʦڶڱ¡
07.04.08, δٲʿйҿƼеóĽѵ
07.04.08, Weldonţӡ
07.04.08, ȫںˡպ˭
07.04.08, 㡶һҽ¡
07.04.08, 桶ҽй
07.04.08, 13Ƕ˼Ժʿ⡷
07.04.08, ġ޹泭Ϯ
07.04.08, ƽߡDCDIS-BڹڷĺͻȡȲΪ
07.04.08, ˮЧ֮һ֤
07.04.08, LieblingҴǿǻڻĻԡ
07.04.08, 졶һ޳ܡ˵ã
07.04.08, ϷձС

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

йƻʵҽִ

ӢȻ200745
ߣJane Qiu
ӷ룩

йһĲļƻͼùϵҽҩִ׼й
չٴоĽҩڵļͿ
ɸоǷҪùϿĿѧ׼

ȻйǰҲͶҽҩǸ15ƻķı䣬ö
öʽ𡣸Ŀܵ16ί֧֣ɿƼҽҩ
ͷ

Ƽֹ＼ĸ޽ǿ˵й10Ԫ13
ǧԪҽҩоͿδԤǰ74ǧԪ
ʽ56

˿δܹҽƲȥҽԺĹң
ҽҩйصĹҽƵʽҲ10ﵽ85ԪҽҩԹžΪ
ҽȻҪãرЩûл
򸺵ҽƵĵҽҩֳָ˵

ʩڱ鼰ȫйҽҩļ֮ġȥ꣬ϳ
ɳϴѧһѧŹҫڡҽѧѧ־ϷһƪΪ
ҽҩ£һȫԵıۡŹҫ˵ҽαѧ
Ӧǹҽϵоһ֡

۵ĸڽصȴᶨְ֧ҽɿѧ
йȿҩںܹùŵ׼ϣ2020
ҽҩȫ򻯡ڹȥʮ꣬ҩгһŷ޺
Ľڹйҩİȫ¼½
гݶձڹռݡ

йļƻƶ߱׼ĲԣҩİȫԺЧԿչ
ٴоٽʺĽ켼ҽҩϵͳùʹ淶

йڷĸı˸顣Ҫҩѧ
ҩǰעشҩзԳɷ֣һһɸѡ
³ɹűغͼѪƼǻ
׼ҩﲢδӿ֡µļƻڿдͳɫԭķ
ҽҩҪ۵ķԴƣһҩһ
ضļʹֲȡĸӻϡÿһֻﶼǸ廯ģ
ĳ˵֢״ԡ

ҽҩĴҵߺоԱڵſǷĸǮһ
˵ӭƻһشĽϺҽҩѧУƽ˵
Щ˲Ը͡йҽѧѧԺһλҪĽΪھ
ǧʵͷչ֮ҽѾƣҽִֻ
ʵʡ

ﻯѧѧߡִйαѧͿвΪ
˿վķҲƻΪȻǳ෴ԭ
ֶ֧вҩпѧоΪԼҽ۵ǿǴġҽ
Ļк;ۣǶģܲ⣬
˵Ѿ˴ʽͼ֤ҽ۵ʻһ
񡣡

Ϻҩоҩҩɸѡΰͬ۵㣺Ҫ
ҽҩִǱȥЩ۵ԡ

ЩҲĸüƻû趨㹻ϸĿѧ׼Ȼٴо
ΪҪ֮һǸüƻûо˵ǷӦòա˫ä
оԱͲ˶֪˭ҩ˭ðοٴ顣ңû
ҪҽҩоԱҪڹϿɵĿϷġȥйҽҩ
ܲֻûоͬйҽѧڿϣ
ΰ˵Դûô̫ܻᷢ
䡣

һҹĵûо˵ιʽķ䡣
Щ߾ãڵԴֻǱĳЩŴĴѧо
˵ҪĽչӦöԴ˽иĸȷҽҩʽ
ġĻϺͨѧҩѧԺԺΰԣôʩֻ
С

޽ǿ˵ע⵽Χҽҩۺ⣬üƻѾ㷺
飬Ϊ˽ЩġҽҩֿƼ˾˾ǿָüƻ
ҽҩչԭͳԶ򣬶漰ϸڣ˵ᷢԾ
˵ʵʩЩܡ

йЩƻʱǷῼߵĵģĿԴ
˱˽ֹۡڷչҽҩͷãΰ˵Ը
ʧ

News
Nature 446, 590-591 (5 April 2007) | doi:10.1038/446590a; Published 
online 4 April 2007


China plans to modernize traditional medicine
Jane Qiu, Beijing

Abstract
Government initiative aims to meet scientific standards.

China has announced an ambitious attempt to bring the ancient practice 
of traditional Chinese medicine (TCM) into line with modern standards. 
The government says it will expand basic and clinical research, and 
improve the testing and developing of TCM remedies for export. But 
critics question whether the research will meet the scientific 
standards necessary for international recognition.

Although China has invested in TCM before, the 15-year plan involves a 
change of direction and will receive significantly more money. The 
project is backed by 16 Chinese ministries, spearheaded by the 
Ministry of Science and Technology (MOST), the Ministry of Health and 
the State Administration of Traditional Chinese Medicine (SATCM).

Zou Jian-qiang, director of MOST's health and biotechnology division, 
says the government has earmarked 1 billion yuan (US$130 million) for 
TCM research and development, with the total budget over the next five 
years increasing to at least 5C6 times as much as the previous total 
of 740 million yuan.

In a country where most of the population is not covered by the public 
healthcare system and cannot afford to go to hospital, there is also a 
tenfold increase in money for the TCM-related part of the public 
healthcare system to 8.5 billion yuan. "Chinese medicine, which has 
served the Chinese people since antiquity, still has an important role 
in today's healthcare, especially in areas where people do not have 
access to, or could not afford, treatments based on Western medicine," 
says Yu Wen-ming, deputy director of SATCM.

The initiative comes after heated discussions on TCM throughout China. 
Last year, Zhang Gong-yao, a scholar at the Central South University 
in Changsha, Hunan, sparked a national debate when he published an 
article titled "Farewell to Traditional Chinese Medicine" in the 
Chinese journal Medicine and Philosophy (27, 14C17; 2006). Zhang 
argued that TCM is a pseudoscience and should not be part of public 
healthcare and research.

All sides of the argument have been keenly awaiting the government's 
stance, and it has come down firmly in favour of promoting TCM as a 
science. China is desperate to earn regulatory approval for TCM 
remedies abroad, and hopes to globalize TCM by 2020. The world market 
for Chinese herbal medicine has doubled over the past decade, with 
Europe and the United States being the biggest importers. But the 
patchy safety record of TCM from China has led to a steady decline in 
its exports, and it has lost market share to neighbouring nations such 
as Japan and South Korea.

So China's plan specifies strategies to boost standards, including 
conducting clinical research on the safety and efficacy of TCM remedies, 
encouraging international collaboration, improving manufacturing 
techniques and bringing the drug regulatory system into line with 
international guidelines.

More controversial is the government's shift in approach. Previous 
attempts to develop scientifically tested drugs from TCM have focused 
on isolating active ingredients from the remedies and screening them 
one at a time. This has led to a handful of new treatments, such as 
artemisinin for treating malaria and the decongestant ephedrine, but 
there has been no goldrush of approved drugs. The new plan aims to 
develop methodologies to test TCM's more traditional features and 
principles. The practice takes a holistic approach to disease treatment, 
so rather than using one drug to treat a particular disease, complex 
combinations of plant extracts are used. Each mixture is personalized 
to the symptoms and characteristics of the patient.

TCM practitioners and researchers are still waiting to see whether the 
government will actually come up with the money, but they have 
generally welcomed the plan. "It's a significant step forward," says 
Liu Ping, vice-president of Shanghai University of Traditional Chinese 
Medicine. Some, however, are reluctant to jump on the bandwagon. A 
professor at the China Academy of Chinese Medical Sciences in Beijing, 
who asked not be named, reckons that after thousands of years of 
practice and development, TCM is already close to perfect and that 
modernization will simply distort its essence.

Shi-min Fang, a US-trained biochemist who now runs a website called 
'New Threads' that fights pseudoscience and research misconduct in 
China, is also unimpressed by the plan, but for opposite reasons. He 
is in favour of scientific research into Chinese herbal remedies, but 
thinks the emphasis on testing the theories of TCM is misplaced. "The 
basic concepts of Chinese medicine, such as yin and yang, wu xing (the 
five elements) and the qi (meridian) theory, are inaccurate 
descriptions of the human body that verge on imaginative," he says. 
"The government has already spent a lot of money trying to prove their 
mechanistic basis, but this hasn't gone anywhere."

Wang Ming-wei, director of the National Centre for Drug Screening at 
the Shanghai Institute of Materia Medica, agrees: "To truly modernize 
Chinese medicine, we must first demystify these theories."

Some critics also worry that the plan doesn't set strict enough 
scientific standards. Although clinical research is listed as a 
priority, the plan doesn't specify whether there should be randomized, 
controlled trials in which neither practitioners nor patients know who 
is receiving active remedy and who is getting a placebo. And there is 
no requirement for TCM researchers to publish in internationally 
recognized journals. "Most research on TCM in the past is of poor 
quality, and is published only in Chinese medical journals without 
proper peer-review processes," remarks Wang. "Without a clear position 
from the government, it is unlikely that the situation will change."

Another concern is that the government does not specify how it will 
control the way in which research funding is allocated. Some critics 
feel that resources are currently being circulated only among certain 
favoured universities and institutes, and argue that reform to ensure 
that TCM grants are based on merit is necessary if any real progress 
is to be achieved. Otherwise, as Jia Wei, associate dean of the 
pharmacy school at Shanghai Jiaotong University, puts it, the 
initiative will be just "loud thunder, small raindrops".

Zou says that the government is aware of the controversy and problems 
surrounding TCM, and that the plan, on which it has consulted widely, 
is set to resolve these issues. Su Gang-qiang, deputy director-general 
of SATCM's science and technology department, points out that the plan 
outlines overall principles and long-term directions for the 
development of TCM, rather than going into details, and says that 
further strategies will be published to specify exactly how the 
schemes will be carried out.

Whether the government will take critics' concerns into account while 
drafting these plans remains to be seen, but many are cautiously 
optimistic. "The wind is now right for the development of TCM," says 
Jia. "Let's hope this will not be a missed opportunity."

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

˿԰棩Ŀͨ

http://www.xys-reader.org

Home at xys.org

ڵŬ˿Ҽˡ˿
Ϊ˷˿Ķͼһվվ
¼˿µϣhttp://www.xys.org/xys/µ
£ߡԼʱϢ

Ķ˿ʱҪĳƪʱֻһҳһҳ
ķңʹGoogleȼʱõûʱȺʮҡ
ˣһֱϣ˿վṩӦļܡǰЩӣ
дһĿĳ޸ģڴҼ
ӡ

˿ڷĶͼµĿģҪʵ
¹ܣ

һ 

1ĶʱͨߣԼʱȷݵ¡
2վṩ"Ķ"Ĺܡ磬Ķһƪҽ
ʱϵͳҽйصбΪϵͳڳ׶Σ
ùǿ˹ܵоĶһ֡

 

1 ͨ߻¡
2 ԶԼ̳ӽмùܲõGoogleAPIӿڡ
Ϊ˶Ajax˽⣬ǰĽʾȽϼ򵥣ӭλһͬĽ

 ѡ˿վ

վʱ˿£λʹñվĶʱԴվ
վȡ¡ʱڵûܷķڵ
վַϣõûķ

վڴڲԽ׶ΣϣõҸͽ顣Ϊ
ʵֵĹ

1 Ϊûڹڽͬվͬ¡
2 վԻݣÿ˿ղز¡

л

˴վĽõ˿""˵İͽ顣ڴ˱
ʾл

[] 

1 ˴νվ˿ʱڵ·Χ㣬ʷ˼
ģУʱѾãóȴȤζȻӭ
վھ˿վʡ

2վ"ֲ"վֲһΪ
ѧṩϢάվӭҷʴվ׫д¡
http://www.jp-life.org

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ʮλѧʦڶڱ

ߣһ

һֱ̾ᡰǧͷһżֵϢʮ
λѧʦڱļ ڱļ׷ֻᡷ
http://edu.qianlong.com/ϸһʲôϢ
ֻᱨѧʦԼʵgoogleһѣˣͬһϢѾ
ǧӿˡһֻ֮γԭ֮ƣȻ
ġʦйˡ

һᰮѧĺߣûʱܰһΣЩԾ
ʮλʦ׷ģһѧ󣬾ǣôĴʦ֮û
ۣĪǸ©ˣǣϽȿʦô˵

ƪʵṩĲϣʱ˻صܡֻᡱٿһ죺

331һֵüӡһ죬ͷһɳ
û赲סʦǵĽŲǴеķ糾˷һ
ȥμӡڱļ׷ֻᡣ

ģʦǶˣɡĴᡰˣ

ڱҶæʦǸæѵлһһΣ
ʦƼ

ǧϵǳҡۼ

йϯ ԭйžβĻ ʫ
÷йЭϯ 
ƣйЭϯ 
޲ţȫЭίԱ ̿ίԱḱ 
ңȫЭίԱ йѧ᳤ 
ʤѣйЭᵳԱ Ǵ 
ָ٣йѧѧḱ᳤ ۼ
йɢѧ᳣񸱻᳤ 
޵ѧ־ԭܱ 
黣йѧѧ  ᳤ 
ʯӢйɢѧḱ᳤ 
йѧԺѧооԱ ۼ
㣺³ѸѧԺԺ ʫ 
Ϫйѧḱ᳤鳤 
ȫЭίԱ йѧѧḱ᳤ 
ʣйɢѧḱ᳤鳤 
ӽ꣺ձܱ ۼ
ʤйִѧݳ񸱹ݳ
νйҡ־ 
ΡйЭᴴв  ʫ
ϣѧԺѧооԱ ۼ
裺³ѸѧԺԺ 
Ԫձղ 
йܱ ۼ
ƴ᣺β 
ףžܺβ ר
ѵйִѧݹݳ
캢йɢѧ᳣鳤 
֣鸦عɼܲ ʫ
ǣйС˵ѧḱ᳤ ʡۼЭḱϯС˵ۡ    
ͬ᣺йʫѧ鳤  ʻʫ˱ʻ鳤

㿴ƣййЭϯϯǴˣ
йС˵ѧᡢйɢѧᡢйѧѧᡢйѧѧᡢйʫ
ѧḱ᳤鳤ˣʫˡѧҡɢļˣй
ѧԺоԱˣý帺ˡ࣬һһоˡ
֮㿴֪Ķǡ󡱣Իʦ

ѹйЭϯ÷ڷ˵һ˵
񿪡ĴᡱڱרҪյô붼ѣһ
ôʦˡ

˵ģڱҪôҡ󡢴ʦһ治סҶ
æǶڱˡѧʦǶΪĳ֡
ˡһһλ˲̳ǰ

ڱ

ڱֵϼѧԺԺԳм
ѧע⣬ɴ˿ġһЩֵ÷з
֪ԭίһ֪ȷ²Ȼôࡰ
ѧʦһ𣬵Ȼ˵ѧйصˡ

ʦǡΪڱˡļⲿġ

1	ֻһġļ

ϿļƬȿⱾ;ͺرһ󿪱飨
ʮģɫ£ڱֻ˶Ӻ׵Դأ
档

ǣ׷ʽŴ󵽱˴NӰΪ᳡ĴͼΪ
֮Ļ÷վŴԴ棬ԵúС

ǳª֪ʶļƺһ˵ܻ㣬ܸһ
ģġڱļеһɼֻ֮С
ݡǧϵŸܣ顰ռѧԺ20׫
дĸõƷչʾйߵȽչ֮·Ŀͻ
ͣ˵Ƕйҵϵͳܽᡣ

ֻһļռЩʲôûݶ˵
༭޵ڻϵۣ˽ˡڱļڱ
ѧԺһҲӱصġһԵļ󶼰Ѹֿ
׫´ǡ̸£൥˵ۣ롣
ⲿ飬漯ġġ´ǡ̸֮ɣǧ죬
ءֵע⣬һһļѾѶʮ
һˡ޴ʦΪѱ˴ԼҲսԼġ
桱ȻʦҲðѶʮдֺͱ˴
һļЩǣǿǣ޴ʦհӹƪ
£ں档ǵȴĵڶN½桭Ѿ
θЩоˡߣ

2ڶڱ

ѧʦҪֵģȻҪѧƷˡڼԼĹªŵͬ
ʱϽˡѧԺվ򿪡УļĿһ
Ĵ֣ҵƪνģҷڱ
ԼվǾԲ©ģܳġĽ⼸ƪˣ⼸
ƪҲǴʦзģɼǶڱĿ֮

ҿ⼸ƪݣҲ˵ƪƪڴ룬ʹ
ӴͿֻ֣ۣͨ

˱ʦǷġ֮ʡеļСΣ

ĽڻĴŶûгֻһֻ̤60ǰ
ŷ޶еĹǵʷںɴȴ
ҲĨж˹̩սƽͯײ ˵ʲôأ

ҽߵϯġ¡Żչ
žꡢ趯ڷɣƽһε˷ܡ
䣡

50ƽ4300˿ڵֻʡԴЩô
벻ֻͨҪ̳͹Ƕʿ˹ʹ˹ѪͳҲ緢
ղ۹𺳡ֻҪҲǺǣ

ôҲ벻ͨĺƪĲ䣬Ȼܱڴʦ

ʦǡô˵

༭޵˵ⲿ飬Դԡʷ
ļĿ⡣

С˵ҵ÷˵죬ôʦˣʲôԭأǶ
ڱͬ־˸

ɢļʯӢ˵ڱⱾļ˵ǳŷǳص֣
Ƿġ㷺ģݽ겶кöһȫ ڱ
ⲿļУ¼һЩ´ʺ;һѧζġΪɢҲ
ݣ˵ݵĸ塣йŴһЩ˼桢˵ɫʱȽŨ
£Ҳ֮ıɢ֮С˵Ĺֹ棬ܴһ־
˵ԱȽǿȽŨһЩƷ

ʫ˵ҶⱾ飬Ҳǵɢġѧļȥ
Ұȥ

ۼ˵ҾöڱⱾԵĹ
̣ҳԾľǣǧֵдôƯҾ
дʣҸеǸʫˣĻ˻
սˣѧˣȫһɢļҡһƪر
ʶ⣬˼ϵĺö෢֣Ҿȫ
һ˼ҡ

ѧۼҺоԱ˵ҷԵĿǡйߵȽ
ҵߡߺߡڱļˣΪڱеˣҲΪ
شزһλйҵľӣ
һλ֮ߡߺ߶еԺ

Բһһо٣ֻվϼλߵı¼

ͬ᣺ ǱڵľӢһƽ̨
ָ٣ѧʣʵ١
Ρ־ʿڱ
νһֵ걼Ӱĸо
ϣһʵҵļһķ籩
ƣΪڱơ
޲ţŻơ԰ɫ

дͻȻˡQһλδׯͨ簢
򰢰ˣĴһ£һλ̫үأ
ǵĿڱһϿڱļҲб

룬ҲֻһƽδׯˣûСѧҡڱģ
ʮλ̳ʦôһָ㣬Ҳ֪ˣ̳һǡ

󣬴һ׶ڱʫͣ

Ц
200110£ʡʡί͸Ԭʡ̹ίǳ´
ͬӲԺܵԺŵһӭǺʹ帱
ȺӲԺ͹㳡¥׹Ԣýңѧ
ִĺͼݡ
ȡԺڱԺҹѧרҺɽڻ㱨
󣬽Цˡ
Цˣ 
Цã 
Ц泩 

̤롱ɾһ 
ӭǣ 
ɽ£ 
ˮĻ 
ഺ 
ƮԷ㡣 

һ 
 
ɽѧĴѧ黳 
һ 
㽹 
شذ 
дͷ׳¡ 
ǰ 
ʡĸУܣ 
ȴѧĲ㼤ˡ 
ǰ 
ͷϵƸУʣ 
ȴֹй߽̹ȣ 
ȷ 
δĿ롣 

Цˣ У
ס˼ˡ롱ġ 
ֵĴһ˫˫ 
Ǵһ˫˫ 
ǣ롱ѧ 
󿪷ǰ 
ȥ֯ɽİ˰ش 
ȥλ붫ھȫ򻯵Ĺг 

Цˣ 
롱ѧ 
˷ 
ǡ롱ħ 
Ƿ羰߶õг 
ֻѧһ 
ֻĦ¥һ 

Цˣ 
Ц̸롱ѧ׹Ԣ 
ȵʱ 
Цӭ¥¾Ŀ⡣ 
ЦѲϯ 
Ц䡰롱ĽѧʩС 

Цˣ 
Ϊ롱ĸͽģʽ 
ΪǧѧӲڷɵĳ 
Ϊʽϸġ롱 
ǧҳļУ 
ݷݷѧұٵ¯ 
˲ŵĻ 

Цˣ 
úˮˮ 
ȹ߽̻ĴŮأ 
˽ǿƴ£ 
á롱 
ҷ 
ӳǽ 

Цˣ 
 
ӪΪĿġĳ߰ѧּ 
ʱڻϸ 
 
ġڶϣ̡ո°ѧ 
ؽİڽɽ 
ݴصϼ⣡ 

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ٲʿйҿƼеóĽѵ

δ

ѧоԳΪһϢΪĹһ
ֱݣ Ա˿гɹ϶ڿѧ޷档
˵һٱֵĲʿصйھúϢ߶ȷ
ϺйõĴѧ֮һѧ٣ٻҿƼȽ
ΪϺпƼӢҽѧ˲ţһšǸѧ
ҽԺĳ־ɳġ鷢21͵й
Ϻй߿ˮƽĸѧѵ̵ġ

¼طţ

־1990ѧ1998꿪ʼUCLAʿ1999걻Ϊ
ڡϺС2000UCLA
Assistant Professor Dr. Nguyenʵʿ2002Clinical 
Cancer Researchϵһƪ±ԭ߷ԣȳءDr. Nguyen
ƪµͨѶߣɺܻӰ죬Dr. Nguyen
־ֹһкȻ־Ѿ޷н
ֻȫְعع ľİװ־Ȼ2005ù
ƼȽϺпƼӢϺҽѧ˲ţѧУ
2002-2007ÿоѽ4000Ԫ
ʹ2006˿վͬʽ¶پ־Ȼ200611ѡ
ǧ˲Ź̡ǲҪʣƼѵôܺͺڰͬʱ
ҲܽһЩѵ

ѵ֮һ

ϸ˲ءڣƼ˲Ŷǿ㣬Ϊ
УӦˡһܶ12꣬ûʽְĲʿ
ɼȻʵ˲ŵĻмʮ˲š

ѵ֮

ҿƼȴ󽱵ίйһ־ҪרҵҪϽ
֪ʶ¡ʵ־ٲѷֻ֣ҪPUBMED׾һ
ĿȻΪίܹ⿴Ҫ˾Щʲô־
Clinical Cancer Researchջصƪ£ջغ󻹸ͷ󷢱л
־ϣ˵л־˲˽оͬĻз
л־ƪٰ¡

ѵ֮

оѵҪѧ־2001ùҽܳͽ
ƻ140ĿǡE-Cadherinٰת
ƻƺźŴе塱ʱ޷ֱ32ֱ꣬2006ף־
ûһƪġ140Ԫʲô;ǲö֪
Ŀм¼ܹþ޶ܲ˼

ѵ֮

УҪЧķѧܻơԴ˿վԴʵ¶־
ѧѾ8ˡֻҽԺڲ޹ʹصһ
£ʹûġ͸ͷܶĿǲϵġѧķܶĿ
ǹһѧǴϼʹһĺ׶ѧҲ
вġ¼˾ٱScience־ûջ
֮ǰ׶ѧֹͣ˻Ŀй־ڹѾ
֣±ջأ˿Ѿ8µ£ѧûκβ
ȡʩļ󣬶200611»ýĽִʽ
ʵǹ٣ҶĿǰ̵ʮ˶ʿͲʿҲ
ĸӰ졣ѧӦʶѧٵĹϴѧУ
ֻѧУ

ѵ֮

ķѧܵĻıҪԡӸ־ѧ
Կڴѧ֮ķѧܻǷǳеġ⼸
ҼӴԿеͶ룬ѧԵҪԼԼķʽѧ
ֻԵľ㣬ԽԽܡ

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ţӡ

Weldon

ã

    45ա˿ںӣintron¡ţʵ
ᵽţԺ˵ţﺬС־ӡԲ
¡ӡкţѾ־ӡȻڵӹ
Ͽˡһ飬ԭǡӡֲͬͬӹϿ


ϲ鵽£

ҵӪ+աʱ 

----------------------------------------------------------------------
 
йʳƷҵ (2007-2-12 9:11:33)  
  
ڣйҵĿҪ仯һӪա
ʱڵٰ쳬ŮţȶԲƷ
Ӫرˡӡǰˡӡţ
Ʒܵ˹ߵĻӭ

Ӫաʱ

ţĴйƷҵЭƼίԱϯר
˵ҹһҵѴȥһʱҵ۽Ӫ䣬ȴ
Ӫ⡣

ڣţע⵽һ㣬Ƴӡӡ
ƷڼͨӪ+ա˫ãƶӪĸơ

ţƷǰҵζװӪȽ׶
Ĵ£ԣҵʿָţƷڣҵ
Ӫ+աʱ

ҹӪ뷢չ־ΰʿΪţΪӪһ
ס˵ţƷڶȺ70%ߡ
ƽйӪ뷢չҵĽУҪţл⡱

ӡӪ

ţƷĺľˡӡݹʳƷר
ڽܣӡǰзУʵ̼ӡ
㹦ܾCNALйʵҹϿίԱᣩCMAȨ֤
ü֤

ӡֳ峦ʹ20%ͬʱٽ
ơпӪصգǿӪɷյĹЧٽǵ
ڽܼ߲ɷʱʾӡ᳦ֱֱӱ˫
˾˾ãٽЩֳӡ
ʹк٣ǿڼĵ


ţƷҲţա֮һش£Ϊ
ˡӪա˫عЧıҵעӪյ
״ 

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

պ˭

ȫں˵BLOG
http://blog.sina.com.cn/u/4cb48db6010008zd

ƺ˴ٲʿǵȤʷϣʵǲ
֪һҺıϲ磺Ҵ׬
˾̨ѻ׬߶ˡ˼۸߳ͨţһ
ϵġݡͨջǸúˮˮóɳɡ

νиĽ涼ͬʱֻǴ˰
λʿ֮˳ۣ٣鷳˵Ļûһ
Ա֮ԼŪŪžͺгˣ˵ⶼǼٵģⲻҲ
ô

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

һҽ



ҽַۣ֧ϳģǵ22ǰҸմҽѧԺҵٴ
һʮŮߣھԱȽ죬ũҵֹ
ʪԹؽףûкܺõƷһʱ˵׼
һƫԶũ壬˵һʮҽ洫ܷʪЧ
ãԺ˵ȥˣҽԶڸҩУõ
ǰӹҩ󣬵ڶû

һҿһֽϵĹ棬úܿЦ:洫ܷƽ˲Ϊʲô
Ц?֪ʮǰøûǰ˲йǲ֮
֢ý˲ľֻ·һʱùߵôû
ܷ׳λ?ǰҩSARSߣͶ޶о
ҩư̲ܿЦҲʲôҽоhivĸȾ
ƺҩĶԼƻƲҩԿ̲о
Ƽ´ս糵ʵһ־硣

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ҽй

ߣ

ҽйĴͳҽѧȻѧķ룬Ƕҽ̬Ⱥ
ȴǵԸҽҲйѧ̵

ǿ1929ҽ֮ʱйʱڡԶ
İҽųڸߵȽ֮⣬ҽľȻеı
û񽨹˹١ҽ֧߿ͨʾ
ȸַʽԸͨ˰ҽųҽ
ҽ֧߳ڹ췢ǻܸʲô

ҽִҽƶеĽ˱һѧ⣬ԴҽƼ
̸ԴƶȲ̸Դ̸ĵһЩһ
͸һ顱ʲôģ˸ͲܳΪִˣ
˼ά̫ˡȻЩҲ֪ҽˣҽи⣬
˵ϹҲסҲ񱣬ֻҪйģֻҪǹϵģ
ǳŲҲҪҲ֪äĿԴ󣬱ɣ˼ȡ
ǲǲİ

һũƵ۵ҽһʼƭ˵ũƵǰο
ЧͲˡϸһҽйҽѧʷǵĵʷһΰ
ΰһֱڻþСʷ˾ĴѾ{һ
ŻеĽԶաҼƶ׻񿴵Եĸӡ

˵ҲѰ죬ǲֱƷǰҽߣһӰ쵽
ȨһӰ찲Žᡣҽĵʧҽѧ
˸ҽ

йʱҽعʱ

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

Ƕ˼Ժʿ

ߣ13

˺˿ķʽǲһ֬ᡢǵΪΪ
ܵʦϵѧʼ٣ôʦĺѷ֡ȴã
Ϊܵʦϵѧӿʼҵļһֱ٣ʦľȻû
֣Ҳͦѵõģڻͬѧ飬ԺʿĵͨѶ
ʦûΣжΣǻǷ²ۡǶ˼
⡣

һƵû٣һʵΰĿгɹô
гɹĵһ˭ԺʿʦҲȷٿ
ȷһ㣬һԲǻѧ

ڶѧáѧ̬ȶԴ飬û٣
֤뷨⡱ʧܵģôܵʧ˭ʧܵ
ԺʿʦʲôӰ죿ôڶʿͬѧʲô
Ӱ죿

ɹ˹ԼʧʧǱˣ˴Ҳڱˡָ߻
ͷյĺ£ʲôʱ䵽ҵͷϰĽing

ô˵й״£ԺʿԱҳ飬Ǳ
ʾ塣ȻΪԺʿûй˵Ժʿǽҷ
ٶѣˡ

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

޹泭Ϯ

ߣ

ʦ

ã

һֱܹע˿վǳлǴȷĿѧ֪ʶ
ٺͳսľġ߻ҵĳϮ
ʹûıһУΨһģԶҵ

һֱαѧͺܶƷĴ١޹ұȽϲһ
ƷƣƳġˬᡱƷ棬سϮǽ
Ԫ㽶ţ̹棬Ʒ"㽶ţ?????(YOU)",
á??? ??ΪؼGOOGLEٶˡ

ڽԪ㽶ţ̹Уһƿ㽶ţڹ԰
׼ãһܿɰŮӶеϿƬ
͸Ůӡڵڶһƿϵʱʱϵ
СŮһ㽶ĺӣ⼴㽶ǽϡ
ȷд⡣

ԽǳĳϮȴڸ˵Ȩ
ˬĹУ˹ˣһޣƬβĺ
Ҳ㽶ƬıڣԼ͸¶Ϣûκε
κ͸Ķȫ̳Ϯˡ

ĹƬʦáԪ㽶ţ̹桱ؼҲ
ṩһַhttp://www.podlook.com/item/452831޹Ĺ
Ƶûҵޣͨһ¼ģ
ṩģֻиеһͼƬǹƬĽ

ϣڰæע⵽顣˿վϣԿܶ
ѽ¶ٺͿ飬˲¶ĸдšϣ
˿¶һϮ¼

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

DCDIS-BڹڷĺͻȡȲΪ

ƽ

ҿ˿icingcat¶ġDCDIS-BĹʻı&
Ļ˳Ծָеᣡʵˣһֱлɣ
εƽĳѣĻȻһ֤ˡ

21ͳرǽDCDIS-Bڹڷģ⣺

1ȡ߳ѣȴӦ˽˹˾Ʊûиκʽ
ѻ¼֪ͨ˽˹˾Ļأ
2ЩDCDIS-BȻ2-3ʱܳ棬Ѿʧȥѧ
塣
3sciġӡջѧʣǲȫ֣
2006DCDIS־Ĺʻûʵsci
4ѧˮƽܶûϸ
5ȥΪʡʱ䣬д٣

һУ»òҪ׷鿯ҪĳʣΪʲôҪ
ôΪʲôôȱġйǾڹôı
ģڼô ǲΪƲŵѰҳ·ҡײƭ

ǿҺѧ磬жDCDIS-Bڹڷĺͻ
ȡȲΪ

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ˮЧ֮һ֤

ʷ֪ʶڶժ֮ɽ걻ٵԭһģĿ
֤ˮ֮Чߡɽǣ֮۵ѷʵ
﷢֮ʤ֮ԭʼ֮һԸ䡰
ѾҲ
ȫժ¼£ʶԱ
       ʶ

ɽ걻ٵԭ

ĩ꣬ŮŬĺȨŮ˵ķء
һͿءͳμ֮˵עҲǷˮңΪ
˵ȴɽꡰ̫ʢԵʣԪ꣨1621ս
롱꣨1622ɽ꣬ϵɽӴ⵽֮֡
ųнɽĳʥͤ
Ϊ̫氢ǴعҲûзŹ˾ɽ壬
νġͼƻɽķˮ꣨1623̫
氢ǴǰصΪʤ֮
ߣ㴿 ǿ  ժԡĲ20063ڣ

ǣ²ޣȺ˥΢˭֮ժ¼ͬʱʷ¼
ʶա
ʮ꣨1618£Ŭԡߴޡ죬
˳ݡӵȳǣȫ𶯣ҲСɶɽ²ţ
ʮΣ
Ԫ꣨1621꣩£ŬʴΧս
ųơǡʧء˻ռɶСʮǣǨ

Ԫ꣨1621£͢ΪɶԣΪɶѲ
Ȩգڹӵʮ򣬶͢о
бֻǧࡣԱҲͬţ͢Ĳ
ԡ
£Ŭ෢ɺӶ͢һʼڻ
䡢·ٵķ룬ֹع⵽ķԡ
ѱɢڸǱڳһ̬ƣܿʧأ
ֻӡʮǣռƬء
ʧݺ͢㱻꣨1625ʮ£͢
ն
꣨1636̫ƵۣŴ壬Ԫ¡
ʮ꣨1644ʮճɼúɽ¶ʮ
ءʮ³һжྩǼ䣬ԭƫһɶ٣һԾ
Ϊԭ»ʵۣʽΪ֮µȫȨ
ժ԰ࡶйͨʷھšʮ

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ҴǿǻڻĻ

Liebling

ϵдԭй԰
http://club.backchina.com/main/viewthread.php?tid=492609&extra=page%3D1&page=1

Ŀǰܶ໪˻ͽȫ˿Էֲƶҵʵ
ҲĿǰȽϵһʵȽ
ΪǶǻͽĻԡǵ￴̵
뼫ƶΰǷңϲΪ֤Լ
Ĺ۵㣬ŷ޸̣ŷ޸Ӹԣһľ
ƭԣôǲ۾ʵΡ

Ҷ֪ϱػͽֲƶϲ
ݣǹ͵֧ߣҲкɫݣǵĲҪԸԣı
ݵ֧ԮЩ߱ϸߣʹǻͽҲֿ̬ȣ
֧ߣҲɫݡϴѡʲʤԺ󣬱ݾкܶ
˺ܲΪǲ֧ԮЩĻͽȴҪ
ƣܲƽϲӦóҮչ͹һ
ͬѧᵽϲʱͱĵس֮Ϊchurch state˵֮
Ϊǹ󡣶ҸϷ绯ǣЩϻͽڶϲݣ
ųϵ۹ذĵطҲ򡣿ǰǳ쫷磬֪
ϲǶôƶܶ˿ӸͲͽ
ߵϲƺѸٳΪƶߡ

2003˾GDPǾͻ֣ᷢǰ15ģ
ǻ̿ıɫݣں15ģȫǻӰ
ϲchurch stateǵ˾GDPȻҪһ

ϲݲ󣬶Ļѧ
֪ŵϺŵĺôѧȫֲڱݵɫݡ
ݣųLiberalݣ˵ܶϱػͽ޵ҧ
ݣΪݲйͬԱͨͬԻǸݣ
2003˾GDPȫģҲӵȫǰеĹʡͲʿٴѧ

ܶͽϲԣǿΪӣ˵̵ĺô
ǡǡ˻ͽΪеĵҲΪƶĵ˵
ķϻͽͷǻͽھϵذϲڶƶ
ϻͽûǵİϲݼܻΪīһҡ

ŷ޾˵ֻһͳϵϷѡǻ
Ƕȿŷ׻ıŷŷ˾ GDPͬôϵı
ݣȴߵϲݡȽ֮㻹˵ڽ̡
Ըԣ


ݾʵݴƴ
--ֵ--(km2)--˿ڣˣ--˾GDP
1.Connecticut-----------18303600Բ-----12973-----3,483,372---$52,546
2.District-of-Columbia---2919716Բ-------176-------563,384---$51,824
3.New-Jersey------------41933479Բ-----20295-----8,638,396---$48,543
4.Massachusetts---------31064406Բ-----21385-----6,433,422---$48,286
5.Maryland--------------24603452Բ-----27934-----5,508,909---$44,661
6.New York--------------85103273Բ----128401----19,190,115---$44,347
7.New-Hampshire----------5439794Բ-----24097-----1,287,687---$42,245
8.Minnesota-------------21211322Բ----217725-----5,059,375---$41,925
9.Illinois--------------50822536Բ----146075----12,365,455---$41,100
10.Colorado--------------18631848Բ----269999-----4,550,688---$40,943
11.California-----------144061245Բ----411013----35,484,453---$40,598
12.Virginia--------------29920007Բ----105738-----7,386,330---$40,507
13.Delaware---------------3297057Բ------5328-------817,491---$40,331
14.Washington------------24652035Բ----176616-----6,131,445---$40,206
15.Alaska-----------------2566641Բ---1518800-------648,818---$39,589
16.Michigan--------------37574476Բ----150779----10,079,985---$39,276
17.Pennsylvania----------48271063Բ----117412----12,365,455---$39,037
18.Rhode-Island-----------4147001Բ------3144-----1,076,164---$38,535
19.Wyoming----------------1885838Բ----253596-------501,242---$37,623
************************************************************************
United-States-------1088160900Բ---9629091---292,928,385---$37,148
************************************************************************
20.Nevada-----------------8322210Բ----286297-----2,241,154---$37,134
21.Hawaii-----------------4642250Բ-----16705-----1,257,608---$36,913
22.Wisconsin-------------20147571Բ----145438-----5,472,299---$36,817
23.Nebraska---------------6380230Բ----200017-----1,739,291---$36,630
24.Vermont----------------2252271Բ-----24887-------619,107---$36,379
25.Ohio------------------41387057Բ----106764----11,435,798---$36,180
26.Florida---------------64285448Բ----151670----17,653,544---$36,145
27.Kansas-----------------9765190Բ----213063-----2,723,507---$35,855
28.Missouri--------------20328601Բ----180486-----5,704,484---$35,636
29.Georgia---------------30797281Բ----152488-----8,684,715---$35,461
30.Oregon----------------12583435Բ----251180-----3,559,596---$35,351
31.Texas-----------------77700699Բ----267338----22,118,509---$35,129
32.Iowa------------------10244107Բ----145790-----2,944,062---$34,795
33.Indiana---------------21527759Բ-----93993-----6,195,643---$34,767
34.Maine------------------4557276Բ-----86026-----1,305,728---$34,136
35.North-Carolina--------28665123Բ----136560-----8,407,248---$34,096
36.Tennessee-------------19889113Բ----109411-----5,841,748---$34,047
37.North-Dakota-----------2104260Բ----182966-------633,837---$33,199
38.South-Dakota-----------2529136Բ----199511-------764,309---$33,090
39.Arizona---------------17978756Բ----295023-----5,580,811---$32,216
40.Kentucky--------------12959833Բ----104623-----4,117,827---$31,473
41.Oklahoma--------------11049943Բ----181089-----3,511,532---$31,468
42.Louisiana-------------14078467Բ----125674-----4,496,646---$31,309
43.South-Carolina--------12960788Բ-----80432-----4,147,152---$31,252
44.Alabama---------------13915237Բ----133667-----4,500,752---$30,918
45.Idaho------------------4212434Բ----216412-----1,366,332---$30,830
46.Montana----------------2824870Բ----381085-------917,621---$30,785
47.Utah-------------------7032344Բ----219931-----2,351,467---$29,906
48.New-Mexico-------------5522070Բ----315113-----1,874,614---$29,457
49.West-Virginia----------5276424Բ-----62628-----1,810,354---$29,146
50.Arkansas---------------7885289Բ----137539-----2,725,714---$28,929
51.Mississippi------------7931187Բ----123584-----2,881,281---$27,527

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

һ޳ܡ˵ã



һǰ

ȫ֡۵⡱̸ˣ½ṹҲר



ҪݺݵĲСӵ˳һƹһ°ġȫ
š

йĻδȥһע˺ܴɵһƪ¡
ȻܳĶȴҵдͳĻ˼ԴۣҲ
κƪϣҿĨ˸ñӡ޹µļֵȡ
漰ҵ˸񡣲ⲻС

ҵġȫ˼ҪԴڳڸʱӴ
ѧĸбȺڣ겡ڡѧⱵڣȫ
Եص塣

ҴϾ̰˶ά±䷨ٵĻʱڣٵʮ
ĳ򾭵һƪݽĻսٵ̨ʮĻۣ
ٵ½ĸ￪źֵġȫΡ֮
Ϊٵոչȥµģ꣬ⷽϼȫռ

ЩϵռУȻҲ̨ʮĻʱڵġ
̸Ļ˿ƪ·ǳ׾ͿҵҲǳţƣ
дҲܺá

߿Ժ׿ƪĶͬһ⣨ȫ
ǡġ˲ɱҪĳЩطصƩ˭Ŀ
ǡġ˺ܶˡǣ˵ǳϮǷǳǿģǲ
˵ùȥģ

С֮ǰѾҵĲﲻϵİŪˣʲôɶûУֻ
һ˵ĿͷԵ˵³Ϯ£־̣
ͲˡʱҸ¶ѾԸ
ɾˡУӵȻǸ쵱⵰Զ⡣
Ҫ

ָ˳ϮɣѾ˽ĳ̶ȡһ
ΰġµġ֣

ҷµļ졶йĻδȥһĳϮ62
¡̸Ļ˿ѹ¡

޳ܡ֪Ե˼һƪ2ֺһƪ
ֵ£ʲôԲ֪ʲôԲгֻǳеƣ
ڲͬһ⣬׽ӰպɿСѹ
ҵ¾һҪǣֻͨͫ׶ûо񾭷
£Ϊ񶾵ˮָسϮȫɣָ㶨
£

ȻûĳϮ£Ǵӹ۵⵽
ṹͬ

޳ܡ֪ԵϮܳϮһġ֡
Ǿ˭Ҫ㳭ϮˣϮֻܳͨһġ֡Ϻ
ġ䡱ΡС˵ҵ¡ûĳϮ
һ£һƪʲôɵģǲɺܶ䡱Ρɵģ
Ȼڡ䡱ΡĳϮûĳϮôʣ
Ϯ֮У

Һƪ¶ǡġõһٶУû
һƪͬģܱǸĿǰһͬ
нӽģа͡аԾ¼ϵ׶
֤ͨƵĻԭּеġʵ©
ˡаʣϮ

һڲ˵ʹõȫͬҲܹҳϮΪ
ǹġΪƪ£ʵϣȫȫͬġɵ
ȫͬµĲصҲȫͬԵصԭּң
ǽ죩ĶȫͬҲȫͬԭķҲȫͬ
Ҳȫͬûһ仰ͬġûһͬġβȫ
ͬмȫͬͷȫͬϽҲȫͬһƪ߼ͽṹ
ģһƪ߰ġɢġĲɸȫͬâȫͬ
ȫͬȫͬȫͬθȫȫͬ 
ʣϮ

Сּνġ۵⡱͡½ṹ˵½


ԡ½ṹжҳϮ˵ȥġֽṹ
ֻǳĵҪΪֽṹϵĴͷܷ㣬Ҳܺǣ
һһ򾡵ЧڲȫʱõҲ
֡½ṹһһɵĹ۵гһ·ȥԼĹ۵
һܵĲܶ˶ֽṹдġֽṹձģ
˭רֻҪΪĵҪ˭á

дС˵ռǵĽṹдС˵õҲռǵĽṹ¾ͳϮ
˵ùȥ𣿼Ȼ˵ڡ½ṹϳϮΪʲô˵
ڡ½ṹϳϮ򾭣

ԣһֲרġ½ṹж˳ϮȻǲͨġ
ʣϮ

ԡ۵⡱жҳϮ˵ȥġҪ֪ȫ
۵㡱ԭģҲԭģʱӦ
ʵġ绯Ӱдƪ£ڴ֮ǰһƪ
ȫ˼ͳˡ1907꿪ʼѾߡ

ڶٴȵġŷ塷йѧ19074ڣоУ
֪άֹѧ֮˵˳ʱ֮󣬹̲ŷ岢˹ʱ

ǟRġŷʷУĻʽ΢ŷ
ĻйŷȥǧЧˣ֡ҳ
ӡݣ

ĻʱڹĻ۾ơ֮֡Ĵǣʮ
ĳ򾭣ڱƣȫ֮ɡȫ۵
һڳ򾭵ƷгֵģƪвûСȫ
ۣڡȫֻܽᡢۺǰ˵Ĺ۵㣬
ѵ̸ˡȫҾͲ̸ˣӵĵȫ
̸Ƿˡء͡СĿܣΪҪٷ֮ٵ
ɫұ˵ıǰ˶̣Ҳӵйĵ
£йʵ׶˽ĿһƩҶڵУ

һϵȫǳϮκһдͳĻ
ˣһЩΪ۵⡱Ȼ£Ʃ磬
ҵġ۵⡱Ҫǡ̡רߵĻ񹤾ߡ
Щ۵ʱһֱڶûжı䣬κҪң붼ܲ
·ʵѾ˷ͳߵһֹʶѾ˵˭ԭ
ָֻ˭˵˲˵ֻǣ˭۵⡱
ø롢λ⡣

УAд̸ǡѧ⣨κδ
õ⣩BдҲ̸ѧ⣨κδѾõ
⣩BͳϮA˵ùȥ𣿼Ȼ˵ڡ۵⡱ϳϮΪʲ
ô˵ڡ۵⡱ϳϮ򾭣

ԣһϵġ۵⡱ж˳ϮȻǲͨġ
ʣϮ

ǰУҵġȫԿάʷС˵δȥ
̣Ҫԡ׹ӳʽսʿ̬ΪйġԿά桱ṩһ
ԵĴ𰸣ҪȥǸߡȻʼҵġŶҵ
ΪΪŶñȡҩûҪɡȡ¡
Ϊشʮɡ˳ķ
ӰӶûСʣϮ

ʮУϰϵķֳˣԭּɣϡ
ɣԴɣҪɣɣQɣ뵱Ȼɣɣ
ɣĻɣɣĻɣ쳬ԽɡȻÿһɶ
˼̵ķûһ䡱һΡԭġġ۵
⡱иӰӶûСʣֺϮ

µġܽᡱУ඼ҵԭƩ磬Ұ
ءڵһλΪءԵ֪ʶ
Ȩ£θںһߣֻƣɶ˸ɥʧ
ֻܡʥԡЩԡǱ˽ӻɬġͳȻ
ˡ¡˵һءҪԡҿ
ءġ۵⡱иӰӶûСʣֺ
Ϯ

ڡع鴫ͳУΪᶯʱڣ
תʱڡתʱӦü֡ı׶ֻɸ
һġĸ￪šҲͬˣ̽ˣڼ屾
λ£³ȶԿϵͳӶҪѧ̬ȡֻ
顱ȨģͱȻˡڳ֢ȳ֢
Ķǣʹǡ䡱ķʥ֮ԡͼÿնǳ
ġʥ֮ԡӦִิӵ⡣ġ۵⡱
иӰӶûСʣֺϮ

ڡĻʵķУҸĻʣĻ
ԣĻԣĻԣĻԣĻĲԡҶ
ЩһһвһԡȫΪһ
̬ۣһơȡҲ;ˡȫֶֻ
Ŀġֵġ۵⡱иӰӶûСʣֺ
Ϯ

ڡĻչơУΪͳĶѺʱеġ
һ̥ꡢ˥ϡĹ̡϶˴ͳ
ġʱԵļֵеÿһ仰ÿһλÿһ֣ˡġ
֣иӰӶûУһ׷صƷСͣ͵ĵ۹
ײתڸĻ֤ͳѾ̣ǲһ
ΣȻټҵĳĲġ۵⡱ʣֺϮ

һţƺܽᣬ˵Ҽʱ֪ʶӲŴ
ʱġ֢ʱȡƣġ۵⡱
иӰӶûСʣֺϮ



֤ȷ£˿ָر˳ϮȻǿԵġǣ
ûйԵ£ԵĻֹªֹ֪
ԣȻûκΡ䡱ΡϮ֤ݣǡ̲ס
ǵ棬˴ףں棬й֡Ȼû
ĳϮǴӹ۵⵽½ṹͬޱȶ񶾵ԣͼĨڱ
˸Ͳֻǡ޳ܡˡ󣬻ҵǣСӻװð
ƹࡢΡϵĽ顰ԼεΪ
˿ĶߵǸʣΪʲô

СӵѾһһˡ֮Բô
ΪҸֻٽо

Ķ߿ϸƪ£ÿһ㡱ʵݡ
ءȡȡϵİաĵķȵȣԼжϡ


ע410һѳġĻۡеġȫ
ɡҲϴ͵Ǽġꡱ

ڡ⡷һ㲹



һµ

йĻδȥһ200672530дɵģ
ڹ죬һ22ǧ֣µĻظУҺӲûû˵
ܣۡҰ䵽3֣ڹ췢˳
û˿˿ʱҾѶ䡢Ҫɾ
һЩ޸ģ±ѹ23ǧ֣ݽաʵҲ˶
ĳЩطϾ䡢ᡣ

ƪ´д꣬ȥ˽µʱ䡣д֮ǰ
ϡͻȥһµʱ䣬ŵеȣûзŵ
ԭʼϸࡢӡ

Ĳ

ڡϮָأѾһУһ⡣ٲһ
¡ֻֻԽ̸Խƪ֮Ҳ̸ˡ

СԡûĳϮΪɣûгκ֤ݣӢ
ĵóˡϮĽۡһ

һѹ

Ȼҵ¡ûĳϮ

ǣ۵ͬ

ģǣ½ṹͬ

ɡС϶ҳϮȫɡΪ

һڡѹ˿ϿµĶߣ֪
ҵһص㡣һǣд£ӲԼ۵ͬ
֧ԼĹ۵㣬Ϊоɵɵġֵֹģֻ
Ȥҹ۵ĻӶСᳫȫ
ѹ϶ҧҡϮΪʲô˵дƪ
ʱѹТȡ֮򾭵ˡأ

˿ϹָҳϮҹĲһҲ
ˡС⼸컹ҵĲϵ˵ǳϮġѾ
رۡҶ֪СʲôĪǣַңҲ˵
ûʲôɹ㣬Уһһײɣ

ڡûĳϮѾ˵ʲôȻû
ĳϮ¡Ȼһƪ2ֵ£ûκηն
ҧͬϮĽ֡ʣһƪʲôɵģǲ
ɺܶ䡱ΡɵģȻԼ˵˲ڡ䡱Ρ
ĳϮûĳϮôʣϮ֮У

ڲڡ䡱ΡϮ£նһҧ˳Ϯ
֣ⲻô㿪ʲôЦ

ڡ½ṹµڶصǣд£һ㶼дһ
ΡǰԡǰԵ֣Ȼݷֳһġ֮Сڣ
дһ㶼дǰԶֱӷֳСڡ
ҹҽᶡʮʿڵԷɵȼƪ£ô
Ϊ˱ĶҲҵķ

ƫҪ˵ͬô򾭡ΰȶ֡½ṹ
˶ù֡½ṹҲгֶĹ۵㣬Ȼһ·ȥ
ܵĲ˵ҵº¡½ṹͬΪʲô˵
ºͳ򾭵¡½ṹͬ

һֲרġ½ṹ϶ƪǡϮʲôЦ

ģڡ۵⡱һƪг˰5-12
һһ⡣Ͳ˵ˡ

ˡ䡱ΡĳϮΪǳϮ֮⣬һѾѾõġ۵
⡱ȫġͬô϶ǳϮأ˵ҵº
¡۵ͬΪʲô˵붭Тȡ֮򾭵
˵¡۵ͬ㿪ʲôЦ

48 

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

С

2007-04-08Ϸձ

Соʮ꽥ɡѧСƷź𡰾

С

Сʮר

ʾ

ҶܶʫһЩĺʫһˮĹԣ
ǡϣԼдʫϣԼҲһǡ

дλˣ1997411뿪硣ںܶ
ıһǡ

ֽС

СӵӵУСǡһλʫˣ
һλ˼ңһͯʿһԡɺ͸˼ˡ

ǰѧԺѧ֣ΪСʮ괴һ
ܣ˹ڡǷ׼ѽڡۡ

ͬʱСʮ꣬ɼżŵ֣
ȻССоʮ꽥ɡѧСƷź
֮ơ

С·ʼС

ÿ4£ϼСܻ᲻ڶƼ
Сʮ꣬ΪǰûκελżԷһС
ʮίᡣ

ݰ411ա415աС·λ5
13գСռʫл᣻Сʮĺ͡һֻ
еFLASH

ȥͳһ˹Сӣ˱ѵ·ɽ
Сڲϱһ򵥵ԸСġ˿һ
ȥСӹ¤ѾСԵӦ
Ϥ˱ѯ

ʱвμ߽̤ϴ¤г̣;ɽ
ŭ׽Ա뾰Ϣ֮أԲι۵֪
߾ս֮¤ŪũԲιСӵĵط
(ɷӡ԰С)ȡȻ˹ţСڡƽʱ
ȻڣСӵŪũˮվɿ˽ӲӵͲ


ûиıģʮ䣬СЩ׷ĽĿеӡ󡣡
ԶһǺˣ߽˻ǺˡԼĵ٩һ1
90ĸ߸ӣпһͷϵļпţпݺύ
һ·᳾·ǴӸĳ߳ġǡʱ༭
ĵһӡ

кܶ׫˵СҲָݣееƦ
Ǻϣڻް֮ԼһƬͲ˻Ǻͻƽ
ء

һֻе

һȺ߹

ʮ֮ı̫̫ࡣĲ̾һд
һҪѵöࡱС˲۲۵ĳҡĶ߿
󣬴ġʱѶĳ֮ã
С̤ЬһһɵضԼС˵Էѳ
һӡˢ˵дĹ־ڡдһ䣬
鶼ˡ

ʮǰʹٻ绪ѧҪ ̨ϱϵѧ
Сڹû֪ȣƷͨϵķ̡
ʱԡһԴӡʽڴѧУ԰
ȺдġĶˡںķģƷѾ
ͳƣֻܳһ԰֡

С༭ԼдɵӰ棬ԼƷ
Ӱ졣10ƷڻѾǵأֵĸ弸ھ
ȫص˵

10ǰСߵʱĸѹ˵Ÿո45꣬û
бͽܡ翪ʼƽСѧ߰˵С
ӽɵͯģĬܺȤԶԶʱĳ
ѧ

أʮʱ䣬Сķ˿ȺѸ׳Ϊ֪ǳ
2001ͬС߹ˡת
Ӵ˿ʼͬ·ˡ߹ҵؽű˴
СʱһصġӯȫġҸЩ
ҡĳڶг˿ͼС
Ǹ˼΢İء

ڡһֻеľ£߹ǿʼСַ
׷ĬȤ֣ʫ衢С˵ȵʽʵĹע
ķԼɵ׷ЩֺἯ֣ƽÿ
һٶ

ͬк顡

߹ţСЩ˲Ʒ21һ
ԶȥʲôҲҡȻСƷе˶
һƬʱĻع֮Сʹһ֣һǽ
ԼʽģһǵȥӪ죬񿨶άŵɪɶ
ںһ֣ʹڱĻĵҰʽ±󣬺ڲԼ
д׳־дڶ

УܵģСʷԿѶһ
ĮϷ̬ȣǻ۵۾͸ĵĵƫġ
ǵȱһַ˵ġʣҲǹά˵ġ
ǿҵθСˣʹǻۣȴ˲һ
ж

Сȥ5ʱ̳̳£ΪС
еƷһֱظԼ֤ԼĴΪһԵ˵ĺԣ
ֶԹΪһ۵߼ʽзڡ֮
Ҳʢдµһ߹ը۶ϡСж
йͳĻǡϷʺͳСеġ
СȻĵķй۵Ͻ

СĿճ־õĳݺͷգͬȴ൱һ
ʱڱѰζļĬСʱϷĩļ
ɼ̳ڶࡰɡλ̳֡ĿǶ˶С
ûпΪȤʵϣλȥʱſʼΪ֪д
֣Ȼɱ̳𶯣ѧ199810ڿ
ķġѣһʾʮݴܲɷõʮλ
УԼһ˱ʾϲС飬żɡ䡢
´塢ְס׫̸С

ԽԽۼҵĹעС֡ļѡд桱
ĳӶ̲ͼгСλǰ졢׷ûһλ
ٷϡҡϯ̳ܡʮбһѧƣ
ƷθߵλáƷδĴԣ
ƽ߼ΪĿĵĴˣ˷ζĿ»
ķ̡

С졡

³Ѹߺ70꣬ǻੲݵ׷ʣڽһ
ȫܵõ𰸵ġα⡱ҲСͷϡ˵
˵ʱһݾڰ˾ȥɽԹ죬
һƬҶҵһʫͷϡľȷʫ
ͨͨһλôСأֿܵס̴컨׹ĳô
ᱻЭձࡱôܻ˷һ˵ﵽʱ׼ġۡ
ôǰʱ¹ѧ߹˱˵ġйѧ۶
𣿡ִر׫֡СԻͼģ
żҵǽйѧ˼

FLASH硢ʫ衢չ桢רվܣߺ
Сڸֲʽɺϳ˳һֱ
δı䡪׷ƽȣǻۣԶȤСΪǱ
˸һַͷɵ֪Ķͯ

ӽǵðδ龰100һλϵ
ͼĳѲ˵Ҫһ飬߽С˵
100Ժ󣬵5֣һһС

źǣұҲδҷ·йͷʣֺû
ʵӡһкǽˣַ·Ǹոտʼĳ˵
λܲҵسΪԸСһġһ˸еߵ
̫磬Ҳһˡ

һϣ޷ҪЩЩȤ¡Ը
һɹСǷѾ㣿

׫ġߡɺʵϰԷ

(XYS20070408)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

һΪ˰޷˿վĹ˽˿վĶ̬ؿ
˿ʼбxys@yahoogroups.com

ʼбÿ췢һ˿վ¸µϣÿµ׷һÿ
Ŀ¼ʼбĶμ롰˿֮ѡ
ʼбxys_friends@yahoogroups.com

ù䶩ġù䣬ܿ޷յ
Ƽ䣺yahoo.com, hotmail.com, gmail.com

ġ˿ʼбĵ䷢һհż

xys-subscribe@yahoogroups.com 

塢ͣ˿ʼбͣ䷢һհż

xys-unsubscribe@yahoogroups.com 

Ͷxinyusi@yahoo.comôıļͶ塣

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

